Literature DB >> 8898798

Hospital services for stroke care. A European Perspective. European Study of Stroke Care.

R Beech1, M Ratcliffe, K Tilling, C Wolfe.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is a common cause of mortality and morbidity in Europe and a major consumer of healthcare costs. However, outcomes from stroke vary significantly across Europe, raising the issue of the extent to which the delivery of care varies across Europe.
METHODS: A multicenter, multinational study collected data on hospital admission for stroke. These included patient baseline characteristics, clinical status, and use of inpatient services.
RESULTS: Initial results examined inpatient services in nine hospitals in six countries. Statistically significant differences existed between hospitals in key processes of care, most notably in the areas of (1) mean length of stay (11 to 39 days) and median length of stay (8 to 21 days), (2) percentage of admissions receiving brain imaging (30% to 98%) and neurosurgery (0% to 31%), and (3) percentage of admissions with an identified "need" who received physiotherapy (44% to 90%) and occupational (0% to 65%) and speech (0% to 59%) therapy. Although there were significant hospital differences (P < .001) in the case mix of admissions in terms of level of consciousness, presence of incontinence, prestroke Rankin Scale score, and age, these did not explain the differences in care across sites.
CONCLUSIONS: There is geographic inequity across Europe in the care a stroke patient can expect to receive. Ongoing analysis will examine the link between European variations in service use and outcomes, in terms of mortality, handicap, and functional ability, as a means of indicating which patterns of care are the most effective.

Entities:  

Mesh:

Year:  1996        PMID: 8898798     DOI: 10.1161/01.str.27.11.1958

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Basic characteristics of hospital stroke services in Eastern Hungary.

Authors:  L Mihálka; I Fekete; T Csépány; L Csiba; D Bereczki
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.

Authors:  M Chambers; J Hutton; J Gladman
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

3.  Hospital-based stroke care in Ireland: results from one regional register.

Authors:  C W Fan; R McDonnell; Z Johnson; S O'Keeffe; M J Crowe
Journal:  Ir J Med Sci       Date:  2000 Jan-Mar       Impact factor: 1.568

4.  The uptake and costs of guidelines for stroke in a district of southern England.

Authors:  C D Wolfe; N Stojcevic; A G Rudd; F Warburton; R Beech
Journal:  J Epidemiol Community Health       Date:  1997-10       Impact factor: 3.710

5.  Predictors of resuming therapy within four weeks after discharge from inpatient rehabilitation.

Authors:  Sharon K Ostwald; Kyler M Godwin; Hee Cheong; Stanley G Cron
Journal:  Top Stroke Rehabil       Date:  2009 Jan-Feb       Impact factor: 2.119

6.  Variations in care and outcome in the first year after stroke: a Western and Central European perspective.

Authors:  C D A Wolfe; K Tilling; A Rudd; M Giroud; D Inzitari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

7.  Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register.

Authors:  Juliet Addo; Ajay Bhalla; Siobhan Crichton; Anthony G Rudd; Christopher McKevitt; Charles D A Wolfe
Journal:  BMJ       Date:  2011-02-24

8.  Inequalities in stroke patients' management in English public hospitals: a survey on 200,000 patients.

Authors:  Antonio Ivan Lazzarino; William Palmer; Alex Bottle; Paul Aylin
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

9.  An evaluation of a multidisciplinary team for intermediate care at home.

Authors:  Roger Beech; Wanda Russell; Richard Little; Sally Sherlow-Jones
Journal:  Int J Integr Care       Date:  2004-10-04       Impact factor: 5.120

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.